P-006 - A RADIATION-BASED 6-GENE-SIGNATURE FOR NON-METASTATIC NSCLC
P-023 - ANALYSIS OF QUALITY FACTORS IN THE TREATMENT OF LUNG SBRT
P-029 - ARTIFICIAL INTELLIGENCE APPLIED TO AN AUTOMATIC BONE MARROW CONTOURING DESIGN.
P-045 - CHEMORADIOTHERAPY AND DURVALUMAB CONSOLIDATION FOR UNRESECTABLE STAGE III NSCLC
P-046 - CHEST WALL PAIN IN LUNG SBRT PATIENTS: DOSE-VOLUME CORRELATIONS
P-051 - CLINICAL OUTCOMES OF SOLITARY PULMONARY NODULE TREATED WITH SBRT
P-059 - COMPARISON SBRT TREATMENT TIME FOR 6 - 10 FFF
P-085 - DOSIMETRIC QUALITY OF PTV IN CLINICAL DOSIMETRY OF PLEURAL MESOTHELIOMA
P-086 - DURVALUMAB AFTER CHEMORADIOTHERAPY (CRT) IN UNRESECTABLE STAGE III NSCLC
P-117 - EXTRACRANIAL STEREOTACTIC RADIOTHERAPY IN EARLY-STAGE LUNG CANCER:
P-128 - FIRST CASE OF HEMITHORACIC PLEURAL RADIOTHERAPY AFTER LUNG-SPARING SURGERY
P-130 - FIRST EXPERIENCE WITH DURVALUMAB AFTER CONCOMITANT CHEMORADIOTHERAPY IN LUNG CANCER
P-175 - IMPACT OF PLANNING TARGET VOLUMEN IN OUTCOMES IN LUNG CANCER.
P-188 - INITIAL DOSIMETRIC PARAMETERS ANALYSES BETWEEN PHOTONS & PROTONS.
P-194 - INTRAFRACTION MOTION DURING DIBH IN LUNG/LIVER STEREOTACTIC BODY RADIOTHERAPY
P-202 - LATTICE RADIOTHERAPY: A ONE INSTITUTION EXPERIENCE
P-211 - LONG-TERM-RESULTS AFTER SBRT IN ELDERLY-PATIENTS WITH EARLY-STAGE NON-SMALL-CELL LUNG CANCER
P-222 - METABOLIC AND PATHOLOGIC RESPONSE IN LUNG CANCER WITH NEOADJUVANT TREATMENT.
P-235 - NSCLC RADIOMICS MACHINE LEARNING CLASSIFICATION FOR PREDICTING DISEASE PROGRESSION
P-241 - OBSERVATIONAL STUDY OF LUNG CANCER IN THE PROVINCE OF SEVILLE.
P-248 - OUR EXPERIENCE WITH ADRENAL SBRT